Skip to main content

Pa Shun International Holdings Limited (0574.HK)

Hong Kong Stock Exchange Healthcare Medical - PharmaceuticalsView data quality →
40.4Fair

ValueMarkers Composite Index

Top 6%#42,225 of 44,714

DCF data not available

Piotroski
4/9
Neutral
Beneish
0.86
High Risk
Altman
-5.92
Distress
DCF Value
-
N/A
ROIC
4.3%
Low
P/E
-
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Pa Shun International Holdings Limited (0574.HK) — VMCI valuation read

Across 120 indicators, Pa Shun International Holdings Limited (0574.HK) lands at VMCI 40/100. The Healthcare sector median is 50, so the 10-point below-median read is the active comparison. Pillar weighting on the score: Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%.

No material Form 4 disclosures landed on 0574.HK in the past 30 days. Quiet insider tape removes one signal source; the active reads stay with the trailing-twelve-month financials and the next 10-Q.

**Investor frame.** On Value, 0574.HK trades at 25.0x earnings, 39% above the Healthcare median of 18.0x; the EV/EBITDA delta of -2.0x reinforces that single line. On Quality, ROIC of 9.0% trails the Healthcare median (10.0%) by 1.0pp. On Risk, net debt to EBITDA of -2.1x leaves covenant headroom for 0574.HK on the trailing balance sheet.

0574.HK fell 2.0% over the trailing 7 days, with a -7.1% read on a 30-day basis.

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in 0574.HK’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.